ePrints

A Phase IIa Clinical Trial of KAND567, Fractalkine Receptor Inhibitor, in Patients with ST-Elevation Acute Myocardial Infarction after Percutaneous Coronary Intervention

Lookup NU author(s): Yasemin Ekinci, Dr Gavin RichardsonORCiD, Professor Ioakim SpyridopoulosORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Ekinci Y, Richardson GD, Spyridopoulos I

Publication type: Article

Publication status: Published

Journal: Journal of Pharmacology and Experimental Therapeutics

Year: 2024

Volume: 389

Issue: S3

Print publication date: 01/06/2024

Online publication date: 13/05/2024

Acceptance date: 01/03/2024

ISSN (print): 0022-3565

ISSN (electronic): 1521-0103

Publisher: American Society for Pharmacology and Experimental Therapeutics

URL: https://doi.org/10.1124/jpet.472.935010

DOI: 10.1124/jpet.472.935010

Altmetrics

Share